Trials / Completed
CompletedNCT04828772
A Study of Anticoagulation Treatment Patterns and Outcomes of Participants Hospitalized With Coronavirus Disease 2019 (COVID-19) in Japan
Real-World Evidence for Anticoagulation Treatment Patterns and Outcomes of Patients Hospitalized With COVID-19 in Japan - A Database Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 9,282 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to describe demographic and clinical characteristics of participants who are hospitalized due to coronavirus 2019 (COVID-19), treatment use for COVID-19 and COVID-19 symptoms, and composite outcomes of COVID-19. This study will also compare composite outcomes between COVID-19 participants treated with and without anticoagulant therapy during follow-up period.
Conditions
Timeline
- Start date
- 2020-08-17
- Primary completion
- 2021-01-31
- Completion
- 2022-02-07
- First posted
- 2021-04-02
- Last updated
- 2022-05-12
Locations
2 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT04828772. Inclusion in this directory is not an endorsement.